[go: up one dir, main page]

CN111978236A - Preparation method of N-substituted-3-morpholinyl-4-phenylseleno maleimide compound - Google Patents

Preparation method of N-substituted-3-morpholinyl-4-phenylseleno maleimide compound Download PDF

Info

Publication number
CN111978236A
CN111978236A CN202010816745.0A CN202010816745A CN111978236A CN 111978236 A CN111978236 A CN 111978236A CN 202010816745 A CN202010816745 A CN 202010816745A CN 111978236 A CN111978236 A CN 111978236A
Authority
CN
China
Prior art keywords
substituted
reaction
morpholinyl
maleimide
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010816745.0A
Other languages
Chinese (zh)
Other versions
CN111978236B (en
Inventor
吴戈
马云飞
石珊珊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wenzhou Medical University
Original Assignee
Wenzhou Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenzhou Medical University filed Critical Wenzhou Medical University
Priority to CN202010816745.0A priority Critical patent/CN111978236B/en
Publication of CN111978236A publication Critical patent/CN111978236A/en
Application granted granted Critical
Publication of CN111978236B publication Critical patent/CN111978236B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/456Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)

Abstract

本发明涉及一种N‑取代‑3‑吗啉基‑4‑苯硒基马来酰亚胺化合物的制备方法,在有机溶剂中,氧气条件下,以苯硼酸、硒粉、吗啡啉和N‑取代马来酰亚胺为反应原料,在过渡金属铜催化剂、银盐、配体和碱的共同协同催化作用下,通过四组分串联反应得到N‑取代‑3‑吗啉基‑4‑苯硒基马来酰亚胺化合物。所述方法反应条件简单、产物的产率和纯度高,为N‑取代‑3‑吗啉基‑4‑苯硒基马来酰亚胺化合物的制备开拓了合成路线和方法,具有良好的应用潜力和研究价值。The invention relates to a preparation method of an N-substituted-3-morpholinyl-4-phenylselenoyl maleimide compound. In an organic solvent, under oxygen conditions, phenylboronic acid, selenium powder, morpholine and N ‑Substituted maleimide is used as the raw material for the reaction, and under the joint catalysis of transition metal copper catalyst, silver salt, ligand and base, N‑substituted‑3‑morpholinyl‑4‑ is obtained through a four-component series reaction Phenylselenomaleimide compound. The method has simple reaction conditions, high product yield and high purity, opens up a synthetic route and method for the preparation of N-substituted-3-morpholinyl-4-phenylselenylmaleimide compounds, and has good application potential and research value.

Description

一种N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物的制备 方法A kind of preparation of N-substituted-3-morpholinyl-4-phenylselenyl maleimide compound method

技术领域technical field

本发明属于有机化合物合成技术领域,尤其是涉及一种N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物的制备方法。The invention belongs to the technical field of organic compound synthesis, in particular to a preparation method of an N-substituted-3-morpholinyl-4-phenylselenyl maleimide compound.

背景技术Background technique

3,4-双官能化马来酰亚胺作为核心骨架广泛存在于海洋天然生物碱和具有重要生物活性的抗肿瘤活性分子、候选药物分子和AIE荧光材料中,例如:G2细胞周期检查点激酶Isogranulatimide、LPS诱导巨噬细胞抑制剂Himanimide A、抗乳腺癌药Camphorataimide B、特异性Porcupine抑制剂、海洋生物碱aqabamycin G和肝脏x受体激动剂GSK3987。此外,马来酰亚胺还可以进行丰富多样的官能团转换合成琥珀酰亚胺、四氢吡咯和2-吡咯酮等衍生物。因此,探索从廉价易得的原料高效构建3,4-双官能化马来酰亚胺成为当前有机化学、药物化学和材料科学研究的热点之一。3,4-Difunctionalized maleimide as the core skeleton widely exists in marine natural alkaloids and antitumor active molecules with important biological activities, drug candidate molecules and AIE fluorescent materials, such as: G2 cell cycle checkpoint kinase Isogranulatimide, LPS-induced macrophage inhibitor Himanimide A, anti-breast cancer drug Camphorataimide B, specific Porcupine inhibitor, marine alkaloid aqabamycin G and liver X receptor agonist GSK3987. In addition, maleimide can also be converted into various functional groups to synthesize derivatives such as succinimide, tetrahydropyrrole and 2-pyrrolidone. Therefore, exploring the efficient construction of 3,4-difunctionalized maleimides from cheap and readily available raw materials has become one of the hotspots in current organic chemistry, medicinal chemistry and materials science.

Figure BSA0000216752810000011
Figure BSA0000216752810000011

3,4-双官能化马来酰亚胺的活性分子Reactive molecules of 3,4-difunctionalized maleimides

另外一方面,考虑到芳硒醚化合物在药物研发中具有潜在的应用价值,发展将芳硒基引入马来酰亚胺分子结构中的方法引起了合成化学家们的关注。Baidya课题组报道了过渡金属钌催化马来酰亚胺与二芳基二硒醚的氧化硒基化反应,然而,二芳基二硒醚的预先制备和贵金属钌催化剂的使用,使得该反应不能够有效地应用于药物分子的后期修饰,减少了创新药物分子的发现机会。因此,发展新型的硒基化试剂,对马来酰亚胺直接催化胺芳硒基化将是一种有效的策略,一步反应即可实现碳-氮键和双碳-硒键的高效构建和含药物分子的引入。最近,我们课题组报道了铜催化马来酰亚胺的胺硒基化反应(OxidativeAminoarylselenation of Maleimides via Copper-Catalyzed Four-Component Cross-Coupling,Organic Letters 2019,21,3,745-748)。考虑到芳硒基和马来酰亚胺母核结构在创新药物研发的重要性,因此,对于简便、易于处理、底物廉价易得的原料来制备N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物显得尤为重要,尤其是利用廉价易得、稳定、实验操作方便的苯硼酸作为苯基化试剂制备N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物的反应,至今未曾报道,仍存在继续进行研究和探索的必要,这也是本发明得以完成的基础和动力所在。On the other hand, considering the potential application value of arylselenide compounds in drug research and development, the development of methods to introduce arylselenoyl groups into the molecular structure of maleimide has attracted the attention of synthetic chemists. Baidya's group reported that transition metal ruthenium catalyzed the oxidoselenylation of maleimide and diaryl diselenide. However, the pre-preparation of diaryl diselenide and the use of precious metal ruthenium catalyst made this reaction impossible. It can be effectively applied to late-stage modification of drug molecules, reducing the chance of discovery of innovative drug molecules. Therefore, the development of new selenylation reagents to directly catalyze amine arylselenylation of maleimide will be an effective strategy, which can realize the efficient construction of carbon-nitrogen bonds and double carbon-selenium bonds in one step. Introduction of drug-containing molecules. Recently, our research group reported the copper-catalyzed amine selenation of maleimides (Oxidative Aminoarylselenation of Maleimides via Copper-Catalyzed Four-Component Cross-Coupling, Organic Letters 2019, 21, 3, 745-748). Considering the importance of arylselenyl and maleimide core structures in the development of innovative drugs, it is necessary to prepare N-substituted-3-morpholinyl-4 from facile, easy-to-handle, inexpensive and readily available starting materials. -Phenylselenylmaleimide compounds are particularly important, especially the preparation of N-substituted-3-morpholinyl-4-phenylselenyl by using phenylboronic acid, which is cheap, easy to obtain, stable, and convenient for experimental operation as a phenylation reagent The reaction of the maleimide compound has not been reported so far, and there is still a need for continued research and exploration, which is also the basis and motivation for the completion of the present invention.

发明内容SUMMARY OF THE INVENTION

本发明所要解决的技术问题是N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物的制备方法的合成路线问题。The technical problem to be solved by the present invention is the synthetic route problem of the preparation method of the N-substituted-3-morpholinyl-4-phenylselenyl maleimide compound.

为解决以上技术问题,本发明提供下述技术方案:For solving the above technical problems, the present invention provides the following technical solutions:

一种N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物的制备方法,在有机溶剂中,氧气条件下,以苯硼酸、硒粉、吗啡啉和N-取代马来酰亚胺为反应原料,在过渡金属铜催化剂、银盐、配体和碱的共同协同催化作用下,通过四组分串联反应得到N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物;A kind of preparation method of N-substituted-3-morpholinyl-4-phenylselenoyl maleimide compound, in organic solvent, under oxygen condition, with phenylboronic acid, selenium powder, morpholine and N-substituted N-substituted-3-morpholinyl-4-phenylselenyl group was obtained through a four-component series reaction under the synergistic catalysis of transition metal copper catalyst, silver salt, ligand and base using leimide as the raw material. Maleimide compounds;

上述的反应过程,可用下述的反应式表示:The above-mentioned reaction process can be represented by the following reaction formula:

Figure BSA0000216752810000021
Figure BSA0000216752810000021

所述苯硼酸、硒粉、吗啡啉和N-取代马来酰亚胺的摩尔比为3∶3∶3∶1。The molar ratio of phenylboronic acid, selenium powder, morpholine and N-substituted maleimide is 3:3:3:1.

(1)过渡金属铜催化剂(1) transition metal copper catalyst

本发明中的过渡金属铜催化剂是醋酸铜、溴化亚铜、三氟甲磺酸铜、氯化亚铜、溴化铜或碘化亚铜,优选为碘化亚铜,以摩尔量计,所述碘化亚铜的用量与所述N-取代马来酰亚胺用量的20%。The transition metal copper catalyst in the present invention is copper acetate, cuprous bromide, copper triflate, cuprous chloride, cupric bromide or cuprous iodide, preferably cuprous iodide, in molar terms, The amount of the cuprous iodide is 20% of the amount of the N-substituted maleimide.

(2)银盐(2) Silver salt

本发明中的银盐为氧化银、碳酸银、醋酸银或硝酸银,优选为碳酸银,以摩尔量计,所述银盐的用量与所述N-取代马来酰亚胺用量比为2∶1。The silver salt in the present invention is silver oxide, silver carbonate, silver acetate or silver nitrate, preferably silver carbonate, on a molar basis, the consumption ratio of the silver salt to the N-substituted maleimide consumption is 2 : 1.

(3)配体(3) Ligand

本发明中的配体为三苯基膦、三环己基膦、1,10-邻菲罗啉或2,2′-联吡啶,优选为1,10-邻菲罗啉。以摩尔量计,所述配体的用量为所述N-取代马来酰亚胺用量的20%。The ligand in the present invention is triphenylphosphine, tricyclohexylphosphine, 1,10-o-phenanthroline or 2,2'-bipyridine, preferably 1,10-o-phenanthroline. On a molar basis, the amount of the ligand is 20% of the amount of the N-substituted maleimide.

(4)碱(4) Alkali

本发明中的碱为碳酸铯、碳酸钾、碳酸钠、磷酸钾或磷酸钠中的至少一种,优选碳酸铯,以摩尔量计,所述碳酸铯的用量与所述N-取代马来酰亚胺用量比为3∶1。The alkali in the present invention is at least one of cesium carbonate, potassium carbonate, sodium carbonate, potassium phosphate or sodium phosphate, preferably cesium carbonate, in molar terms, the consumption of the cesium carbonate and the N-substituted maleyl The imine dosage ratio was 3:1.

(5)有机溶剂(5) Organic solvent

本发明中的反应溶剂为有机溶剂,所述有机溶剂为二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮、1,4-二氧六烷、1,2-二氯乙烷、乙腈、甲苯、四氢呋喃中的至少一种,优选N,N-二甲基甲酰胺。The reaction solvent in the present invention is an organic solvent, and the organic solvent is dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, 1,4 -At least one of dioxane, 1,2-dichloroethane, acetonitrile, toluene, and tetrahydrofuran, preferably N,N-dimethylformamide.

(6)反应温度(6) Reaction temperature

本发明的制备方法中,反应温度为120-140℃,非限定性地例如可为120℃、130℃和140℃,反应温度优选140℃。In the preparation method of the present invention, the reaction temperature is 120-140°C, such as 120°C, 130°C and 140°C without limitation, and the reaction temperature is preferably 140°C.

(7)反应时间(7) Response time

在本发明的制备方法中,反应时间并无特别的限定,例如可通过液相色谱仪检测目标产物或原料的残留百分比而确定合适的反应时间,其通常为30-36小时,非限定性例如为30小时、32小时、34小时或36小时,反应时间优选36小时。In the preparation method of the present invention, the reaction time is not particularly limited. For example, a suitable reaction time can be determined by detecting the residual percentage of the target product or raw material by liquid chromatography, which is usually 30-36 hours. 30 hours, 32 hours, 34 hours or 36 hours, the reaction time is preferably 36 hours.

(8)分离纯化(8) Separation and purification

在一种优选的实施方式中,反应结束后的后处理步骤可为如下方法:反应结束后,将反应液冷却后加入水和乙酸乙酯萃取,将有机相用无水硫酸钠干燥,过滤至鸡心瓶,然后旋掉溶剂,将浓缩物通过柱色谱分离,以石油醚和乙酸乙酯混合液为洗脱剂,收集洗脱液,浓缩后得到目标产物。In a preferred embodiment, the post-processing step after the reaction is completed can be the following method: after the reaction is completed, the reaction solution is cooled and then added with water and ethyl acetate for extraction, the organic phase is dried with anhydrous sodium sulfate, and filtered to chicken heart bottle, then spin off the solvent, separate the concentrate by column chromatography, use the mixture of petroleum ether and ethyl acetate as the eluent, collect the eluent, and concentrate to obtain the target product.

本发明提供的N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物的制备方法具有如下有益效果:The preparation method of the N-substituted-3-morpholinyl-4-phenylselenoyl maleimide compound provided by the present invention has the following beneficial effects:

a)反应高效率、高收率、后处理简便;a) high reaction efficiency, high yield and easy post-processing;

b)利用廉价易得的硒粉作为硒基化试剂;b) using cheap and readily available selenium powder as a selenoylation reagent;

c)利用廉价易的铜作为催化剂;c) Utilize cheap and easy copper as a catalyst;

本发明以苯硼酸、硒粉、吗啡啉和N-取代马来酰亚胺为反应原料,在过渡金属铜催化剂、银盐、配体和碱的共同协同催化作用下,通过四组分串联反应得到N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物。本发明反应原料廉价易得、产物的产率和纯度高,为N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物的制备开拓了合成路线和方法,为双取代马来酰亚胺衍生物的分子设计与合成提供新思路,具有重要的社会意义和经济意义。In the invention, phenylboronic acid, selenium powder, morpholine and N-substituted maleimide are used as reaction raw materials, and under the joint catalysis of transition metal copper catalyst, silver salt, ligand and base, a series reaction of four components is carried out. The N-substituted-3-morpholinyl-4-phenylselenomaleimide compound was obtained. The reaction raw materials of the invention are cheap and easy to obtain, the yield and purity of the products are high, the synthesis route and method are opened up for the preparation of N-substituted-3-morpholinyl-4-phenylselenoyl maleimide compounds, and the double-substituted The molecular design and synthesis of maleimide derivatives provide new ideas and have important social and economic significance.

具体实施方式Detailed ways

下面通过具体的实施例对本发明进行详细说明,但这些例举性实施方式的用途和目的仅用来例举本发明,并非对本发明的实际保护范围构成任何形式的任何限定,更非将本发明的保护范围局限于此。The present invention will be described in detail below through specific examples, but the purposes and purposes of these exemplary embodiments are only used to illustrate the present invention, and do not constitute any limitation to the actual protection scope of the present invention, nor do they limit the present invention. The scope of protection is limited to this.

以下实施例所给出的新化合物的数据和纯度均通过核磁共振鉴定。The data and purity of the novel compounds given in the following examples were identified by nuclear magnetic resonance.

实施1:Implementation 1:

N-环己基-3-吗啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of N-cyclohexyl-3-morpholinyl-4-phenylselenomaleimide compounds

Figure BSA0000216752810000031
Figure BSA0000216752810000031

在室温下,将苯硼酸(0.6mmol,3.0equiv)、硒粉(0.6mmol,3.0equiv)、吗啉(0.6mmol,3.0equiv)、N-环己基马来酰亚胺(0.2mmol,1.0equiv)、碘化亚铜(0.04mmol,0.2equiv)、1,10-邻菲罗啉(0.04mmol,0.2equiv)、碳酸银(0.4mmol,2.0equiv)、碳酸铯(0.6mmol,3.0equiv)、和2mL N,N-二甲基甲酰胺加入到反应管中,然后充入氧气,并且置换三次,在140℃反应温度下搅36h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,用食盐水萃取,分离出有机相,用无水硫酸钠干燥,过滤至鸡心瓶,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙酸乙酯为9∶1),产物为黄色液体,收率80%,产物重量为67mg。At room temperature, phenylboronic acid (0.6 mmol, 3.0 equiv), selenium powder (0.6 mmol, 3.0 equiv), morpholine (0.6 mmol, 3.0 equiv), N-cyclohexylmaleimide (0.2 mmol, 1.0 equiv) were combined ), cuprous iodide (0.04mmol, 0.2equiv), 1,10-o-phenanthroline (0.04mmol, 0.2equiv), silver carbonate (0.4mmol, 2.0equiv), cesium carbonate (0.6mmol, 3.0equiv), and 2 mL of N,N-dimethylformamide were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 140° C. for 36 h. The reaction mixture was cooled, then diluted with ethyl acetate, extracted with brine, the organic phase was separated, dried with anhydrous sodium sulfate, filtered into a chicken heart flask, then the solvent was spun off, and the product was isolated by column chromatography (eluting). agent: petroleum ether:ethyl acetate 9:1), the product is a yellow liquid, the yield is 80%, and the weight of the product is 67 mg.

所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:

1H NMR(500MHz,CDCl3):δ7.30-7.28(m,2H),7.26-7.23(m,2H),7.19(t,J=7.0Hz,1H),4.11(t,J=4.70Hz,4H),3.96(tt,J=8.3,3.4Hz,1H),3.66(t,J=4.70Hz,4H),2.10-2.03(m,2H),1.82(d,J=3.1Hz,2H),1.68-1.66(m,2H),1.34-1.18(m,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.30-7.28 (m, 2H), 7.26-7.23 (m, 2H), 7.19 (t, J=7.0 Hz, 1H), 4.11 (t, J=4.70 Hz) , 4H), 3.96 (tt, J=8.3, 3.4Hz, 1H), 3.66 (t, J=4.70Hz, 4H), 2.10-2.03 (m, 2H), 1.82 (d, J=3.1Hz, 2H) , 1.68-1.66 (m, 2H), 1.34-1.18 (m, 4H);

所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:

13C NMR(125MHz,CDCl3):δ170.2,166.4,149.5,132.4,129.4,129.3,126.6,87.6,66.9,51.4,48.4,29.9,26.0,25.2; 13 C NMR (125 MHz, CDCl 3 ): δ 170.2, 166.4, 149.5, 132.4, 129.4, 129.3, 126.6, 87.6, 66.9, 51.4, 48.4, 29.9, 26.0, 25.2;

所得产物的高分辨质谱数据如下:The high-resolution mass spectrometry data of the obtained product are as follows:

HRMS(ESI):calcd for C20H24N2O3Se[M+Na]+443.0850,found 443.0864.HRMS(ESI): calcd for C 20 H 24 N 2 O 3 Se[M+Na] + 443.0850, found 443.0864.

实施2:Implementation 2:

N-苄基-3-吗啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of N-benzyl-3-morpholinyl-4-phenylselenomaleimide compounds

Figure BSA0000216752810000032
Figure BSA0000216752810000032

在室温下,将苯硼酸(0.6mmol,3.0equiv)、硒粉(0.6mmol,3.0equiv)、吗啉(0.6mmol,3.0equiv)、N-苄基马来酰亚胺(0.2mmol,1.0equiv)、碘化亚铜(0.04mmol,0.2equiv)、1,10-邻菲罗啉(0.04mmol,0.2equiv)、碳酸银(0.4mmol,2.0equiv)、碳酸铯(0.6mmol,3.0equiv)、和2mL N,N-二甲基甲酰胺加入到反应管中,然后充入氧气,并且置换三次,在140℃反应温度下搅36h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,用食盐水萃取,分离出有机相,用无水硫酸钠干燥,过滤至鸡心瓶,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙酸乙酯为9∶1),产物为黄色液体,收率79%,产物重量为67mg。At room temperature, phenylboronic acid (0.6 mmol, 3.0 equiv), selenium powder (0.6 mmol, 3.0 equiv), morpholine (0.6 mmol, 3.0 equiv), N-benzylmaleimide (0.2 mmol, 1.0 equiv) were combined ), cuprous iodide (0.04mmol, 0.2equiv), 1,10-o-phenanthroline (0.04mmol, 0.2equiv), silver carbonate (0.4mmol, 2.0equiv), cesium carbonate (0.6mmol, 3.0equiv), and 2 mL of N,N-dimethylformamide were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 140° C. for 36 h. The reaction mixture was cooled, then diluted with ethyl acetate, extracted with brine, the organic phase was separated, dried with anhydrous sodium sulfate, filtered into a chicken heart flask, then the solvent was spun off, and the product was isolated by column chromatography (eluting). agent: petroleum ether:ethyl acetate 9:1), the product is a yellow liquid, the yield is 79%, and the weight of the product is 67 mg.

所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:

1H NMR(500MHz,CDCl3):δ7.41-7.39(m,2H),7.36-7.22(m,8H),4.72(s,2H),4.16(t,J=4.70Hz,4H),3.66(t,J=4.70Hz,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.41-7.39 (m, 2H), 7.36-7.22 (m, 8H), 4.72 (s, 2H), 4.16 (t, J=4.70 Hz, 4H), 3.66 (t, J=4.70Hz, 4H);

所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:

13C NMR(125MHz,CDCl3):δ170.0,166.3,149.7,136.5,132.3,129.5,129.4,128.6,128.6,127.7,126.7,87.2,66.9,48.5,42.1; 13 C NMR (125 MHz, CDCl 3 ): δ 170.0, 166.3, 149.7, 136.5, 132.3, 129.5, 129.4, 128.6, 128.6, 127.7, 126.7, 87.2, 66.9, 48.5, 42.1;

所得产物的高分辨质谱数据如下:The high-resolution mass spectrometry data of the obtained product are as follows:

HRMS(ESI):calcd for C21H20N2O3Se[M+H]+429.0718,found 429.0726.HRMS(ESI): calcd for C 21 H 20 N 2 O 3 Se[M+H] + 429.0718, found 429.0726.

实施3:Implementation 3:

N-(4-甲基苄基)-3-吗啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of N-(4-methylbenzyl)-3-morpholinyl-4-phenylselenomaleimide compounds

Figure BSA0000216752810000041
Figure BSA0000216752810000041

在室温下,将苯硼酸(0.6mmol,3.0equiv)、硒粉(0.6mmol,3.0equiv)、吗啉(0.6mmol,3.0equiv)、N-(4-甲基苄基)马来酰亚胺(0.2mmol,1.0equiv)、碘化亚铜(0.04mmol,0.2equiv)、1,10-邻菲罗啉(0.04mmol,0.2equiv)、碳酸银(0.4mmol,2.0equiv)、碳酸铯(0.6mmol,3.0equiv)、和2mL N,N-二甲基甲酰胺加入到反应管中,然后充入氧气,并且置换三次,在140℃反应温度下搅36h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,用食盐水萃取,分离出有机相,用无水硫酸钠干燥,过滤至鸡心瓶,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙酸乙酯为9∶1),产物为黄色固体,熔点为116-117℃,收率77%,产物重量为68mg。At room temperature, phenylboronic acid (0.6 mmol, 3.0 equiv), selenium powder (0.6 mmol, 3.0 equiv), morpholine (0.6 mmol, 3.0 equiv), N-(4-methylbenzyl)maleimide (0.2mmol, 1.0equiv), cuprous iodide (0.04mmol, 0.2equiv), 1,10-phenanthroline (0.04mmol, 0.2equiv), silver carbonate (0.4mmol, 2.0equiv), cesium carbonate (0.6 mmol, 3.0 equiv), and 2 mL of N,N-dimethylformamide were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 140° C. for 36 h. The reaction mixture was cooled, then diluted with ethyl acetate, extracted with brine, the organic phase was separated, dried with anhydrous sodium sulfate, filtered into a chicken heart flask, then the solvent was spun off, and the product was isolated by column chromatography (eluting). agent: petroleum ether:ethyl acetate: 9:1), the product is a yellow solid, the melting point is 116-117°C, the yield is 77%, and the weight of the product is 68 mg.

所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:

1H NMR(500MHz,CDCl3):δ7.29-7.19(m,7H),7.12-7.11(m,2H),4.65(s,2H),4.12(t,J=4.70Hz,4H),3.61(t,J=4.70Hz,4H),2.32(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.29-7.19 (m, 7H), 7.12-7.11 (m, 2H), 4.65 (s, 2H), 4.12 (t, J=4.70 Hz, 4H), 3.61 (t, J=4.70Hz, 4H), 2.32(s, 3H);

所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:

13C NMR(125MHz,CDCl3):δ170.0,166.2,149.7,137.5,133.6,132.3,129.4,129.3,128.7,126.7,87.2,66.9,48.4,41.8,21.1; 13 C NMR (125 MHz, CDCl 3 ): δ 170.0, 166.2, 149.7, 137.5, 133.6, 132.3, 129.4, 129.3, 128.7, 126.7, 87.2, 66.9, 48.4, 41.8, 21.1;

所得产物的高分辨质谱数据如下:The high-resolution mass spectrometry data of the obtained product are as follows:

HRMS(ESI):calcd for C22H22N2O3Se[M+H]+443.0875,found 443.0883.HRMS(ESI): calcd for C 22 H 22 N 2 O 3 Se[M+H] + 443.0875, found 443.0883.

实施4:Implementation 4:

N-(4-甲氧基苄基)-3-吗啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of N-(4-Methoxybenzyl)-3-morpholinyl-4-phenylselenomaleimide Compounds

Figure BSA0000216752810000042
Figure BSA0000216752810000042

在室温下,将苯硼酸(0.6mmol,3.0equiv)、硒粉(0.6mmol,3.0equiv)、吗啉(0.6mmol,3.0equiv)、N-(4-甲氧基苄基)马来酰亚胺(0.2mmol,1.0equiv)、碘化亚铜(0.04mmol,0.2equiv)、1,10-邻菲罗啉(0.04mmol,0.2equiv)、碳酸银(0.4mmol,2.0equiv)、碳酸铯(0.6mmol,3.0equiv)、和2mL N,N-二甲基甲酰胺加入到反应管中,然后充入氧气,并且置换三次,在140℃反应温度下搅36h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,用食盐水萃取,分离出有机相,用无水硫酸钠干燥,过滤至鸡心瓶,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙酸乙酯为9∶1),产物为黄色液体,收率88%,产物重量为80mg。At room temperature, phenylboronic acid (0.6 mmol, 3.0 equiv), selenium powder (0.6 mmol, 3.0 equiv), morpholine (0.6 mmol, 3.0 equiv), N-(4-methoxybenzyl)maleimide Amine (0.2mmol, 1.0equiv), cuprous iodide (0.04mmol, 0.2equiv), 1,10-phenanthroline (0.04mmol, 0.2equiv), silver carbonate (0.4mmol, 2.0equiv), cesium carbonate ( 0.6 mmol, 3.0 equiv), and 2 mL of N,N-dimethylformamide were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 140° C. for 36 h. The reaction mixture was cooled, then diluted with ethyl acetate, extracted with brine, the organic phase was separated, dried with anhydrous sodium sulfate, filtered into a chicken heart flask, then the solvent was spun off, and the product was isolated by column chromatography (eluting). agent: petroleum ether: ethyl acetate 9: 1), the product is a yellow liquid, the yield is 88%, and the weight of the product is 80 mg.

所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:

1H NMR(500MHz,CDCl3):δ7.36-7.20(m,7H),6.86-6.85(m,2H),4.65(s,2H),4.14(t,J=4.70Hz,4H),3.80(s,3H),3.64(t,J=4.70Hz,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.36-7.20 (m, 7H), 6.86-6.85 (m, 2H), 4.65 (s, 2H), 4.14 (t, J=4.70 Hz, 4H), 3.80 (s, 3H), 3.64 (t, J=4.70Hz, 4H);

所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:

13C NMR(125MHz,CDCl3):δ170.1,166.3,159.2,149.7,132.3,130.2,129.4,129.4,128.8,126.7,114.0,87.1,66.9,55.3,48.4,41.5; 13 C NMR (125 MHz, CDCl 3 ): δ 170.1, 166.3, 159.2, 149.7, 132.3, 130.2, 129.4, 129.4, 128.8, 126.7, 114.0, 87.1, 66.9, 55.3, 48.4, 41.5;

所得产物的高分辨质谱数据如下:The high-resolution mass spectrometry data of the obtained product are as follows:

HRMS(ESI):calcd for C22H22N2O4Se[M+H]+459.0824,found 459.0832.HRMS(ESI): calcd for C 22 H 22 N 2 O 4 Se[M+H] + 459.0824, found 459.0832.

实施5:Implementation 5:

N-(4-氟苄基)-3-吗啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of N-(4-Fluorobenzyl)-3-morpholinyl-4-phenylselenomaleimide Compounds

Figure BSA0000216752810000051
Figure BSA0000216752810000051

在室温下,将苯硼酸(0.6mmol,3.0equiv)、硒粉(0.6mmol,3.0equiv)、吗啉(0.6mmol,3.0equiv)、N-(4-氟苄基)马来酰亚胺(0.2mmol,1.0equiv)、碘化亚铜(0.04mmol,0.2equiv)、1,10-邻菲罗啉(0.04mmol,0.2equiv)、碳酸银(0.4mmol,2.0equiv)、碳酸铯(0.6mmol,3.0equiv)、和2mL N,N-二甲基甲酰胺加入到反应管中,然后充入氧气,并且置换三次,在140℃反应温度下搅36h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,用食盐水萃取,分离出有机相,用无水硫酸钠干燥,过滤至鸡心瓶,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙酸乙酯为9∶1),产物为黄色液体,收率65%,产物重量为60mg。At room temperature, phenylboronic acid (0.6 mmol, 3.0 equiv), selenium powder (0.6 mmol, 3.0 equiv), morpholine (0.6 mmol, 3.0 equiv), N-(4-fluorobenzyl)maleimide ( 0.2mmol, 1.0equiv), cuprous iodide (0.04mmol, 0.2equiv), 1,10-o-phenanthroline (0.04mmol, 0.2equiv), silver carbonate (0.4mmol, 2.0equiv), cesium carbonate (0.6mmol) , 3.0 equiv), and 2 mL of N,N-dimethylformamide were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 140° C. for 36 h. The reaction mixture was cooled, then diluted with ethyl acetate, extracted with brine, the organic phase was separated, dried with anhydrous sodium sulfate, filtered into a chicken heart flask, then the solvent was spun off, and the product was isolated by column chromatography (eluting). agent: petroleum ether:ethyl acetate 9:1), the product is a yellow liquid, the yield is 65%, and the weight of the product is 60 mg.

所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:

1H NMR(500MHz,CDCl3):δ7.39-7.37(m,2H),7.32-7.30(m,2H),7.28-7.21(m,4H),7.02(t,J=8.6Hz,2H),4.68(s,2H),4.16(t,J=4.70Hz,4H),3.66(t,J=4.70Hz,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.39-7.37 (m, 2H), 7.32-7.30 (m, 2H), 7.28-7.21 (m, 4H), 7.02 (t, J=8.6 Hz, 2H) , 4.68(s, 2H), 4.16(t, J=4.70Hz, 4H), 3.66(t, J=4.70Hz, 4H);

所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:

13C NMR(125MHz,CDCl3):δ169.9,166.2,162.4(d,JF=246.5Hz),149.7,136.0,132.3(d,JF=3.2Hz),132.2,130.5(d,JF=8.1Hz),129.4(d,JF=9.3Hz),126.7,115.4(d,JF=21.6Hz),87.2,66.9,48.5,41.3; 13 C NMR (125 MHz, CDCl 3 ): δ 169.9, 166.2, 162.4 (d, J F = 246.5 Hz), 149.7, 136.0, 132.3 (d, J F = 3.2 Hz), 132.2, 130.5 (d, J F = 3.2 Hz) = 8.1 Hz), 129.4 (d, J F =9.3 Hz), 126.7, 115.4 (d, J F =21.6 Hz), 87.2, 66.9, 48.5, 41.3;

所得产物的核磁共振氟谱的数据如下:The data of the fluorine nuclear magnetic resonance spectrum of the obtained product are as follows:

19F NMR(470MHz,CDCl3):δ-62.7(s,1F); 19 F NMR (470 MHz, CDCl 3 ): δ-62.7 (s, 1F);

所得产物的高分辨质谱数据如下:The high-resolution mass spectrometry data of the obtained product are as follows:

HRMS(ESI):calcd for C21H19FN2O3Se[M+H]+447.0624,found 447.0639.HRMS(ESI): calcd for C 21 H 19 FN 2 O 3 Se[M+H] + 447.0624, found 447.0639.

实施6:Implementation 6:

N-(4-三氟甲基苄基)-3-吗啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of N-(4-trifluoromethylbenzyl)-3-morpholinyl-4-phenylselenomaleimide compounds

Figure BSA0000216752810000052
Figure BSA0000216752810000052

在室温下,将苯硼酸(0.6mmol,3.0equiv)、硒粉(0.6mmol,3.0equiv)、吗啉(0.6mmol,3.0equiv)、N-(4-三氟甲基苄基)马来酰亚胺(0.2mmol,1.0equiv)、碘化亚铜(0.04mmol,0.2equiv)、1,10-邻菲罗啉(0.04mmol,0.2equiv)、碳酸银(0.4mmol,2.0equiv)、碳酸铯(0.6mmol,3.0equiv)、和2mL N,N-二甲基甲酰胺加入到反应管中,然后充入氧气,并且置换三次,在140℃反应温度下搅36h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,用食盐水萃取,分离出有机相,用无水硫酸钠干燥,过滤至鸡心瓶,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙酸乙酯为9∶1),产物为黄色液体,收率49%,产物重量为49mg。At room temperature, phenylboronic acid (0.6 mmol, 3.0 equiv), selenium powder (0.6 mmol, 3.0 equiv), morpholine (0.6 mmol, 3.0 equiv), N-(4-trifluoromethylbenzyl)maleyl Imine (0.2mmol, 1.0equiv), cuprous iodide (0.04mmol, 0.2equiv), 1,10-phenanthroline (0.04mmol, 0.2equiv), silver carbonate (0.4mmol, 2.0equiv), cesium carbonate (0.6 mmol, 3.0 equiv), and 2 mL of N,N-dimethylformamide were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 140° C. for 36 h. The reaction mixture was cooled, then diluted with ethyl acetate, extracted with brine, the organic phase was separated, dried with anhydrous sodium sulfate, filtered into a chicken heart flask, then the solvent was spun off, and the product was isolated by column chromatography (eluting). agent: petroleum ether: ethyl acetate is 9: 1), the product is a yellow liquid, the yield is 49%, and the weight of the product is 49 mg.

所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:

1H NMR(500MHz,CDCl3):δ7.57(d,J=8.0Hz,2H),7.48(d,J=8.0Hz,2H),7.30-7.29(m,2H),7.26-7.19(m,3H),4.74(s,2H),4.14(t,J=4.70Hz,4H),3.64(t,J=4.70Hz,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.57 (d, J=8.0 Hz, 2H), 7.48 (d, J=8.0 Hz, 2H), 7.30-7.29 (m, 2H), 7.26-7.19 (m , 3H), 4.74 (s, 2H), 4.14 (t, J=4.70Hz, 4H), 3.64 (t, J=4.70Hz, 4H);

所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:

13C NMR(125MHz,CDCl3):δ169.8,166.2,149.6,140.3,132.1,130.0(q,JF=32.4Hz),129.5,129.4,128.9,126.8,126.7,126.2(q,JF=272.3Hz),125.6(q,JF=3.5Hz),87.2,66.9,48.5,41.6; 13 C NMR (125 MHz, CDCl 3 ): δ 169.8, 166.2, 149.6, 140.3, 132.1, 130.0 (q, J F = 32.4 Hz), 129.5, 129.4, 128.9, 126.8, 126.7, 126.2 (q, J F = 32.4 Hz) 272.3 Hz), 125.6 (q, J F =3.5 Hz), 87.2, 66.9, 48.5, 41.6;

所得产物的核磁共振氟谱的数据如下:The data of the fluorine nuclear magnetic resonance spectrum of the obtained product are as follows:

19F NMR(470MHz,CDCl3):δ-62.6(s,3F); 19 F NMR (470 MHz, CDCl 3 ): δ-62.6 (s, 3F);

所得产物的高分辨质谱数据如下:The high-resolution mass spectrometry data of the obtained product are as follows:

HRMS(ESI):calcd for C22H19F3N2O3Se[M+H]+497.0592,found 497.0584.HRMS(ESI): calcd for C 22 H 19 F 3 N 2 O 3 Se[M+H] + 497.0592, found 497.0584.

由上述1-6实施例可看出,当采用本发明的所述方法时,能够以高产率、高纯度得到N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物。It can be seen from the above examples 1-6 that when the method of the present invention is adopted, the N-substituted-3-morpholinyl-4-phenylselenylmaleimide compound can be obtained with high yield and high purity .

实施例7-11Examples 7-11

除将其中的过渡金属催化剂碘化亚铜分别替换为如下的铜盐外,与实施例1相同的方式而分别实施了实施例7-11,所使用铜盐化合物和相应产物的收率如下表1所示。Except for replacing the transition metal catalyst cuprous iodide with the following copper salts, respectively, Examples 7-11 were implemented in the same manner as Example 1, and the yields of the copper salt compounds and corresponding products used were as follows: 1 shown.

表1Table 1

编号Numbering 过渡金属铜催化剂transition metal copper catalyst 反应产率(%)Reaction yield (%) 实施例7Example 7 醋酸铜copper acetate 不反应not responding 实施例8Example 8 氯化亚铜Cuprous Chloride 不反应not responding 实施例9Example 9 溴化铜Copper Bromide 不反应not responding 实施例10Example 10 溴化亚铜Cuprous Bromide 不反应not responding 实施例11Example 11 二氟甲磺酸铜copper difluoromethanesulfonate 不反应not responding

由上表1可看出,当使用其它铜盐时,均没有任何目标产物,由此证明了碘化亚铜是该反应成功的关键因素,且对该反应体系最为有效。As can be seen from Table 1 above, when other copper salts are used, there is no target product, which proves that cuprous iodide is the key factor for the success of the reaction, and the reaction system is the most effective.

实施例12-14Examples 12-14

除将其中的1,10-邻菲罗啉配体分别替换为如下的配体外,与实施例1相同的方式而分别实施了实施例12-14,所使用配体和相应产物的收率如下表2所示。Except for replacing the 1,10-phenanthroline ligands with the following ligands, the same way as in Example 1 was carried out, and the yields of the ligands used and the corresponding products were respectively implemented in Examples 12-14. As shown in Table 2 below.

表2Table 2

编号Numbering 配体Ligand 反应产率(%)Reaction yield (%) 实施例12Example 12 三苯基膦Triphenylphosphine 不反应not responding 实施例13Example 13 三环己基膦tricyclohexylphosphine 不反应not responding 实施例14Example 14 2,2′-联吡啶2,2'-bipyridine 1919

由上表2可看出,当使用三苯基膦或者三环己基膦时,反应不能够发生,利用2,2′-联吡啶作为配体时,产率受到一定的影响,由此证明了1,10-邻菲罗啉是该反应成功的关键因素,且对该反应体系最为有效。It can be seen from Table 2 above that when triphenylphosphine or tricyclohexylphosphine is used, the reaction cannot occur, and when 2,2'-bipyridine is used as a ligand, the yield is affected to a certain extent, which proves that 1,10-phenanthroline is the key factor for the success of this reaction, and it is the most effective for this reaction system.

实施例15-17Examples 15-17

除将其中的碳酸银分别替换为如下的银盐外,与实施例1相同的方式而分别实施了实施例15-17,所使用银盐和相应产物的收率如下表3所示。Examples 15-17 were implemented in the same manner as in Example 1, except that the silver carbonate was replaced with the following silver salts, respectively. The yields of the silver salts used and the corresponding products are shown in Table 3 below.

表3table 3

编号Numbering 银盐silver salt 反应产率(%)Reaction yield (%) 实施例15Example 15 氧化银silver oxide 不反应not responding 实施例16Example 16 醋酸银silver acetate 不反应not responding 实施例17Example 17 硝酸银silver nitrate 不反应not responding

由上表3可看出,当使用其他银盐时,反应均不能发生,由此证明了碳酸银的使用是该反应成功的关键因素,且对该反应体系最为有效。As can be seen from the above table 3, when other silver salts are used, the reaction cannot occur, thus proving that the use of silver carbonate is the key factor for the success of the reaction, and the reaction system is the most effective.

实施例18-21Examples 18-21

除将其中的碳酸铯分别替换为如下的无机碱外,与实施例1相同的方式而分别实施了实施例18-21,所使用碱和相应产物的收率如下表4所示。Examples 18-21 were carried out in the same manner as in Example 1, except that the cesium carbonate was replaced with the following inorganic bases, respectively. The bases used and the yields of the corresponding products are shown in Table 4 below.

表4Table 4

编号Numbering base 反应产率(%)Reaction yield (%) 实施例18Example 18 碳酸钠Sodium carbonate 不反应not responding 实施例19Example 19 碳酸钾Potassium carbonate 不反应not responding 实施例20Example 20 磷酸钾Potassium Phosphate 不反应not responding 实施例21Example 21 磷酸钠Sodium Phosphate 不反应not responding

由上表4可看出,当使用其他无机碱时,没有任何产物,由此证明了碳酸铯的使用是该反应成功的关键因素,且对该反应体系最为有效。As can be seen from Table 4 above, when other inorganic bases are used, there is no product, which proves that the use of cesium carbonate is the key factor for the success of the reaction, and the reaction system is the most effective.

实施例22-29Examples 22-29

除将其中的有机溶剂N,N-二甲基甲酰胺分别替换为如下的有机溶剂外,以与实施例1相同的方式而分别实施了实施22-29,所使用有机溶剂和相应产物的收率如下表5所示。Except that the organic solvent N,N-dimethylformamide therein was replaced with the following organic solvents, respectively, implementations 22-29 were carried out in the same manner as in Example 1, and the organic solvents used and the corresponding products were recovered. The rates are shown in Table 5 below.

表5table 5

编号Numbering 溶剂solvent 反应产率(%)Reaction yield (%) 实施例22Example 22 N,N-二甲基乙酰胺N,N-Dimethylacetamide 不反应not responding 实施例23Example 23 N-甲基吡咯烷酮N-Methylpyrrolidone 不反应not responding 实施例24Example 24 二甲亚砜DMSO 不反应not responding 实施例25Example 25 1,4-二氧六烷1,4-Dioxane 不反应not responding 实施例26Example 26 1,2-二氯乙烷1,2-Dichloroethane 不反应not responding 实施例27Example 27 乙腈Acetonitrile 不反应not responding 实施例28Example 28 甲苯Toluene 不反应not responding 实施例29Example 29 四氢呋喃tetrahydrofuran 不反应not responding

由上表5可看出,使用其他强极性溶剂如二甲亚砜和N,N-二甲基乙酰胺,非极性溶剂甲苯,以及弱配位溶剂乙腈和四氢呋喃均没有任何产物,证明了有机溶剂的合适选择对反应能否进行有着显著的,甚至是决定性的影响。As can be seen from Table 5 above, other strong polar solvents such as dimethyl sulfoxide and N,N-dimethylacetamide, non-polar solvents toluene, and weakly coordinating solvents acetonitrile and tetrahydrofuran did not have any products, which proved that The appropriate choice of organic solvent has a significant or even decisive influence on whether the reaction can be carried out.

综上所述,由上述所有实施例可明确看出,当采用本发明的方法使用过渡金属催化剂(尤其是碘化亚铜)、配体(尤其是1,10-邻菲罗啉)、银盐(尤其是碳酸银)、无机碱(尤其是碳酸铯)和合适的有机溶剂(尤其是N,N-二甲基甲酰胺)所组成的催化反应体系时,使得苯硼酸、硒粉、吗啡啉和N-取代马来酰亚胺化合物在氧气条件下,通过铜催化的四组分串联反应以高产率和高纯度合成得到N-取代-3-吗啉基-4-苯硒基马来酰亚胺化合物,为该类化合物的高效快捷合成提供了全新的合成路线。To sum up, it can be clearly seen from all the above examples that when the method of the present invention uses a transition metal catalyst (especially cuprous iodide), a ligand (especially 1,10-o-phenanthroline), silver In the catalytic reaction system composed of salt (especially silver carbonate), inorganic base (especially cesium carbonate) and suitable organic solvent (especially N,N-dimethylformamide), phenylboronic acid, selenium powder, morphine N-substituted-3-morpholinyl-4-phenylselenylmaleimide was synthesized in high yield and purity by copper-catalyzed four-component tandem reaction of morpholino and N-substituted maleimide compounds under oxygen conditions The imide compound provides a new synthetic route for the efficient and fast synthesis of this type of compound.

最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然科研对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, but not to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: It is still scientific research to modify the technical solutions recorded in the foregoing embodiments, or to make equivalent replacements for some or all of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the technical solutions of the embodiments of the present invention. scope.

Claims (8)

1. A preparation method of N-substituted-3-morpholinyl-4-phenylseleno maleimide compound is characterized in that phenylboronic acid, selenium powder, morpholine and N-substituted maleimide are used as reaction raw materials in an organic solvent under the condition of oxygen, and under the co-concerted catalysis of a transition metal copper catalyst, a silver salt, a ligand and an alkali, the N-substituted-3-morpholinyl-4-phenylseleno maleimide compound is obtained through four-component series reaction;
the phenylboronic acid is: PhB (OH)2
The selenium powder is as follows: se
The morpholine is as follows:
Figure FSA0000216752800000011
the N-substituted maleimide is:
Figure FSA0000216752800000012
the N-substituted-3-morpholinyl-4-phenylseleno maleimide compound is as follows:
Figure FSA0000216752800000013
the copper catalyst is cuprous iodide;
the silver salt is silver carbonate;
the ligand is 1, 10-phenanthroline;
the base is cesium carbonate;
the organic solvent is N, N-dimethylformamide.
2. The method of claim 1, wherein the molar ratio of the phenylboronic acid to the selenium powder to the morpholine to the N-substituted maleimide is 3: 1.
3. The production method according to claim 1, wherein the copper catalyst is used in an amount of 20% by mole based on the amount of the N-substituted maleimide.
4. The production method according to claim 1, wherein the ligand is used in an amount of 20% by mole based on the amount of the N-substituted maleimide.
5. The method according to claim 1, wherein the silver salt and the N-substituted maleimide are used in a molar ratio of 2: 1.
6. The process according to claim 1, wherein the base and the N-substituted maleimide are used in a molar ratio of 3: 1.
7. The method as claimed in claim 1, wherein the reaction temperature is 120-140 ℃.
8. The process according to claim 1, wherein the reaction time is 30 to 36 hours.
CN202010816745.0A 2020-08-12 2020-08-12 A kind of preparation method of N-substituted-3-morpholinyl-4-phenylselenyl maleimide compound Active CN111978236B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010816745.0A CN111978236B (en) 2020-08-12 2020-08-12 A kind of preparation method of N-substituted-3-morpholinyl-4-phenylselenyl maleimide compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010816745.0A CN111978236B (en) 2020-08-12 2020-08-12 A kind of preparation method of N-substituted-3-morpholinyl-4-phenylselenyl maleimide compound

Publications (2)

Publication Number Publication Date
CN111978236A true CN111978236A (en) 2020-11-24
CN111978236B CN111978236B (en) 2022-01-04

Family

ID=73435220

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010816745.0A Active CN111978236B (en) 2020-08-12 2020-08-12 A kind of preparation method of N-substituted-3-morpholinyl-4-phenylselenyl maleimide compound

Country Status (1)

Country Link
CN (1) CN111978236B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114031537A (en) * 2021-09-18 2022-02-11 温州医科大学 A kind of synthetic method of 3-deuterated methylthio-4-morpholinyl maleimide compound
CN114031538A (en) * 2021-09-18 2022-02-11 温州医科大学 Preparation method of 3-deuterated methylseleno-4-morpholinyl maleimide compound
CN115286555A (en) * 2021-11-26 2022-11-04 温州医科大学 Synthetic method of 3-alkynylselendole compound
CN115286552A (en) * 2021-12-30 2022-11-04 温州医科大学 Preparation method of mono-seleno maleimide compound
CN115353477A (en) * 2022-01-19 2022-11-18 温州医科大学 A kind of preparation method of bis-selenomaleimide compound

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108863878A (en) * 2018-02-19 2018-11-23 温州医科大学 A kind of beta-hydroxy selenide compound and preparation method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108863878A (en) * 2018-02-19 2018-11-23 温州医科大学 A kind of beta-hydroxy selenide compound and preparation method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
TAO LENG,等: "Silver-Catalyzed One-Pot Three-Component Selective Synthesis of β-Hydroxy Selenides", 《ADV. SYNTH. CATAL.》 *
XUE GAO,等: "Oxidative Aminoarylselenation of Maleimides via Copper-Catalyz Four-Component Cross-Coupling", 《ORG. LETT.》 *
YAOKUN REN,等: "Synthesis of ArSe-Substituted Aniline Derivatives by C(sp2)-H Functionalization", 《ASIAN J. ORG. CHEM.》 *
YE-FEI YANG,等: "Cu-Catalyzed Radical Selenylation of Olefin: A Direct Access to Vinyl Selenides", 《ADV. SYNTH. CATAL.》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114031537A (en) * 2021-09-18 2022-02-11 温州医科大学 A kind of synthetic method of 3-deuterated methylthio-4-morpholinyl maleimide compound
CN114031538A (en) * 2021-09-18 2022-02-11 温州医科大学 Preparation method of 3-deuterated methylseleno-4-morpholinyl maleimide compound
CN115286555A (en) * 2021-11-26 2022-11-04 温州医科大学 Synthetic method of 3-alkynylselendole compound
CN115286552A (en) * 2021-12-30 2022-11-04 温州医科大学 Preparation method of mono-seleno maleimide compound
CN115286552B (en) * 2021-12-30 2023-10-20 温州医科大学 Preparation method of monoseleno maleimide compound
CN115353477A (en) * 2022-01-19 2022-11-18 温州医科大学 A kind of preparation method of bis-selenomaleimide compound
CN115353477B (en) * 2022-01-19 2023-10-20 温州医科大学 A kind of preparation method of diselenomaleimide compounds

Also Published As

Publication number Publication date
CN111978236B (en) 2022-01-04

Similar Documents

Publication Publication Date Title
CN111978236A (en) Preparation method of N-substituted-3-morpholinyl-4-phenylseleno maleimide compound
CN109705013B (en) A kind of 1-(4-methylbenzyl)-3-amino-4-methylselenomaleimide compound and preparation method thereof
CN101798279B (en) Method for preparing iron-catalyzed pyrrole and pyrrole cyclic compounds
CN112028809A (en) Preparation method of 3-amino-4-phenylseleno maleimide compound
CN107935812B (en) Method for preparing polyaryl substituted naphthalene derivative by reaction of alkyl aryl ketone and tolane under catalysis of ruthenium
CN109651225B (en) Preparation method of 1-methyl-3-morphinyl-4-arylmercapto maleimide compound
CN111333564B (en) A kind of synthetic method of 3-alkylmercapto-1-methyl-4-morpholino maleimide compound
CN111848630A (en) Method for preparing pyrrolo[1,2-a]indole compounds based on alkynyl-substituted aza-p-methylenebenzoquinone
CN108314658B (en) A kind of preparation method of multi-substituted oxazole derivatives
CN111978237A (en) Preparation method of 3-morpholinyl-4-arylseleno maleimide compound
CN112028808B (en) Preparation method of N-substituted-3-methyl mercapto-4-morpholinyl maleimide compound
CN110357805B (en) Preparation method of N-methyl-3-phenylseleno maleimide compound
CN106008402A (en) Epsilon-trifluoromethyl substituted amide preparing method
CN112661690B (en) Preparation method of 3-chloro-4-amino maleimide compound
CN103275027A (en) Synthesis method of alpha-keto amide compound
CN112661689B (en) A kind of preparation method of 3-bromo-4-amino maleimide compound
CN114874139B (en) A kind of synthesis method of 1-benzyl or allyl 3,4-dihydroisoquinoline
CN106892826A (en) A kind of preparation method and application of amine and imines N-methyl
CN106831474B (en) One kind-the α containing alpha-aromatic, β-diamino acid ester derivant and its synthetic method and application
CN108558785A (en) A kind of 5- aryl -2- arylseleno -1,3- oxazole compounds and preparation method
CN106008309A (en) Method for preparing isatin derivative by visible-light photocatalysis
CN111925310A (en) 3-amino-4-arylseleno maleimide compound and preparation method thereof
CN111978235B (en) A kind of preparation method of 3-amino-4-methylmercaptomaleimide compound
CN112724063B (en) Preparation method of 3-iodine-4-amido maleimide compound
CN108912045B (en) A kind of 2-phenylselenoquinoline compound and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant